IRCT201008134561N1
Completed
Phase 2
Effect of N-acetylcysteine on preventation of postcardiac surgery atrial fibrillation
Cardiac Research Center of Tabriz Universityof Medical sciences0 sites240 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Cardiac Research Center of Tabriz Universityof Medical sciences
- Enrollment
- 240
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •primary elective coronary artery and/or valve surgery, older than 18 years of age in normal sinus rhythm. Exclusion criteria: prior coronary
- •revascularization or heart valve surgery, emergency surgery, New York Heart Association class III or IV congestive heart failure, history of AF, hyperthyroidism, inflammatory diseases except coronary artery disease, infection, a left atrium size 70 mm, electrolyte imbalance, and ejection fraction 0\.25
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of N - Acetylcysteine in the prevention of ototoxicity caused by vancomycin.Peritonitis.Peritonitis, unspecifiedIRCT201202148032N2Research Assistance Of Tabriz University Of Medical Science60
Completed
Phase 2
The effect of N-Acetylcystein on prevention of Acute Renal injury due to Cyclosporine Administration in patients undergoing bone marrow transplantatioCondition 1: AML. Condition 2: ALL. Condition 3: Acute Renal injury.Acute myeloblastic leukaemiaAcute lymphoblastic leukaemiaIRCT201306031030N14Hematology Oncology and SCT Research Center60
Recruiting
Phase 3
Prophylactic effect of N-acetyl-cysteine plus Atorvastatin versus N-acetyl-cysteine and Atorvastatin alone for the prevention of contrast induced nephropathyContrast induced nephropathy.Other complications following infusion, transfusion and therapeutic injectionT80.8IRCT20180417039347N1Zahedan University of Medical Sciences250
Completed
Phase 2
The effect of N-acetyl cysteine in preventing mucositis in patients undergoing bone marrow transplantatioCondition 1: Mucositis (oral). Condition 2: AML. Condition 3: ALL. Condition 4: MDS.Oral mucositis (ulcerative)Acute myeloblastic leukaemiaAcute lymphoblastic leukaemiaMyelodysplastic syndromesIRCT201303301030N13Hematology Oncology and SCT Research Center64
Completed
Not Applicable
use of acetyl cystein in prevention of anti-TB drug induced hepatitisdrug induced hepatits.Toxic liver disease with hepatic necrosisIRCT201205259855N1Arak University of Medical sciences